Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer.
Shin SaitoMichihisa KonoHoang C B NguyenAnn Marie EgloffCameron M MessierPatrick H LizotteCloud P PaweletzDouglas R AdkinsRavindra UppaluriPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
These data highlight the contribution of tumor-infiltrating cDC1 in HNSCC aPD1 response and approaches to enhance cDC1 infiltration and function that may circumvent aPD1 resistance in patients with HNSCC.